EKIO 4BIO Spółka z Ograniczoną Odpowiedzialnością (KRS 0000696027, NIP 7282822514) is a Polish company, headquartered in Łódź, Łódzkie voivodeship. EKIO 4BIO operates in: Other retail sale of food in specialised stores (PKD 47.29.Z). Industry: Retail trade. The company has been listed in the National Court Register since September 21, 2017. EKIO 4BIO's most recently reported net revenue was 0 PLN for 2023.
No arrears identified in the analysed sources
No arrears or bankruptcy proceedings identified in the analysed sources.
Business profile - EKIO 4BIO
Identity
- Name
- EKIO 4BIO Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- September 21, 2017
- Registry status as of
- June 3, 2026
- Latest entry
- June 3, 2026
- Founding act
- AKT NOTARIALNY Z DNIA 22.08.2017 R., REPERTORIUM A NR 3390/2017, NOTARIUSZ JOANNA KRASIŃSKA, KANCELARIA NOTARIALNA W ŁO…
Articles of association history (2)
- August 22, 2017: AKT NOTARIALNY Z DNIA 22.08.2017 R., REPERTORIUM A NR 3390/2017, NOTARIUSZ JOANNA KRASIŃSKA, KANCELARIA NOTARIALNA W ŁODZI
- April 19, 2022: AKT NOTARIALNY Z DNIA 19.04.2022 R., REPERTORIUM A NR 3639/2022, NOTARIUSZ KRZYSZTOF KABARA, KANCELARIA NOTARIALNA W ŁODZI, ZMIANA PARAGRAFU 2 UMOWY SPÓŁKI
Activities
Other activities
Address and contact
- Address
- UL. SĄDECKA, 44, 2, 92-014, ŁÓDŹ, POLSKA
- Voivodeship
- ŁÓDZKIE
- District
- ŁÓDŹ
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- Not disclosed in the registry
Risk and payment profile - EKIO 4BIO
Credibility rating
57.6 / 100
Average credibility
Insolvency risk
Low
Elevated threat
Closure risk
36
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organisational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
1
1/9 yrs
Board changes
1
1/9 yrs
PKD changes
0
0/9 yrs
Name changes
1
1/9 yrs
Data from 9 years of registry activity.
Credibility history
Payment reliability score from 2018–2023
Current: C (58/100)
Trend: stable (+0.4 pts/year)
Moderate payment credibility - the company is able to meet its obligations, but some indicators warrant caution.
Trade credit limit history
Standard limit from 2018–2023
Current: 8.6 K PLN
Safe: 3.9 K PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - EKIO 4BIO
Founded
September 21, 2017
8 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
ŁÓDŹ
ŁÓDZKIE
Primary PKD
47.29.Z
Other retail sale of food in specialised stores
Share capital
50.0 K PLN
500 shares total
Shareholders
2
shareholders
Board
2 people
Proxies: 1
Filed years
6 years
2018–2023 · profitable: 1/6
Registry entries
21
latest: June 3, 2026
Risk signals
Revenue
0 PLN
2023
Net profit
-2.2 K PLN
2023
Assets
47.4 K PLN
2023
Equity
37.7 K PLN
2023
EBITDA
-2.2 K PLN
2023
Valuation
25.1 K PLN
Low confidence
Low confidence
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - EKIO 4BIO.
No ratings
Related articles
News
Ambra in 2026: PLN 48.1m capex (+212%), a PLN 1.10 dividend three years running, Cydr Lubelski and Romanian Zarea as the premium engines
Warsaw-based Ambra S.A. (KRS 0000041726, ul. Puławska 336) closed H1 of fiscal 2025/2026 with PLN 556.8m of revenue and PLN 49.0m of net profit, while raising capex by 212% to PLN 48.1m - mainly for the soft-drinks line in Wola Duża and the PLN 11.9m acquisition of a Romanian company. Despite the heavy investment cycle the board is keeping the PLN 1.10 dividend per share for the third year running (~5.9% yield).
News
Answear in 2026: first full year without MCI, PLN 9.3 m net profit, but the supervisory board cuts the 2026 EBITDA target from PLN 100 m to PLN 90 m
Kraków-based Answear.com S.A. (KRS 0000816066) closed 2025 with revenue of PLN 1.7bn (+13% YoY), EBITDA of PLN 56m (+63%) and net profit of PLN 9.3m - a return to the black after a PLN 10m loss in 2024. Poland grew 31%, but CEE was under FX pressure (hryvnia -11% versus the zloty), and a weak Q4 (EBITDA -71% YoY) prompted the supervisory board to cut the 2026 EBITDA target from PLN 100m to PLN 90m and the target price from PLN 50 to PLN 45. It is the first full year after MCI's exit from the shareholder base (10 June 2025); the Bajołek brothers retain control (57.8%).
